UroGen Pharma
URGN
URGN
128 hedge funds and large institutions have $446M invested in UroGen Pharma in 2024 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 29 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
31% less capital invested
Capital invested by funds: $641M → $446M (-$196M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
82% less call options, than puts
Call options by funds: $323K | Put options by funds: $1.83M
Holders
128
Holding in Top 10
1
Calls
$323K
Puts
$1.83M
Top Buyers
| 1 | +$5.53M | |
| 2 | +$5.08M | |
| 3 | +$4.35M | |
| 4 |
Millennium Management
New York
|
+$4.3M |
| 5 |
BlackRock
New York
|
+$3.86M |
Top Sellers
| 1 | -$51.7M | |
| 2 | -$27.3M | |
| 3 | -$12M | |
| 4 |
CAC
Cowen and Company
New York
|
-$3.85M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$2.69M |